Adaptimmune Therapeutics shares owned by Rockefeller Capital Management
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Rockefeller Capital Management
from 13F filings
Historical chart of Rockefeller Capital Management investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Rockefeller Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Rockefeller Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.6k | 12k | 0.13 |
| 2022-12-31 | $2.0k | 2.0k | 1.00 |
| 2022-09-30 | $2.0k | 2.0k | 1.00 |
| 2022-06-30 | $3.0k | 2.0k | 1.50 |
| 2022-03-31 | $4.0k | 2.0k | 2.00 |
| 2021-12-31 | $7.0k | 2.0k | 3.50 |
| 2021-09-30 | $10k | 2.0k | 5.00 |
| 2021-06-30 | $8.0k | 2.0k | 4.00 |
| 2021-03-31 | $10k | 2.0k | 5.00 |
| 2020-12-31 | $10k | 2.0k | 5.00 |
| 2020-09-30 | $18k | 2.3k | 7.70 |
| 2020-06-30 | $20k | 2.0k | 10.00 |
| 2020-03-31 | $5.0k | 2.0k | 2.50 |
| 2019-12-31 | $2.0k | 2.0k | 1.00 |
More positions owned by Rockefeller Capital Management
View all positions for Rockefeller Capital Management